Elicio Therapeutics, Inc.
General ticker "ELTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $160.4M (TTM average)
Elicio Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -31.1%.
Estimated limits based on current volatility of 4.1%: low 1.83$, high 1.98$
Factors to consider:
- Total employees count: 33 (+3.1%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Insufficient capital, Going concern doubt, R&D delays, Manufacturing failures, Regulatory and compliance
- Current price 62.8% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.76$, 12.49$]
- 2026-12-31 to 2027-12-31 estimated range: [3.71$, 10.18$]
Financial Metrics affecting the ELTX estimates:
- Negative: with PPE of -3.1 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -15.99 <= 0
- Positive: Interest expense per share per price, % of 0.92 <= 1.42
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term ELTX quotes
Long-term ELTX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $35.74MM | $44.99MM | $37.71MM |
| Operating Income | $-35.74MM | $-44.99MM | $-37.71MM |
| Non-Operating Income | $0.18MM | $-6.91MM | $-1.86MM |
| Interest Expense | $1.06MM | $0.46MM | $1.13MM |
| R&D Expense | $23.85MM | $33.66MM | $24.90MM |
| Income(Loss) | $-35.57MM | $-51.90MM | $-39.57MM |
| Taxes | $-0.37MM | $0.00MM | $0.00MM |
| Net Income(Loss)* | $-35.20MM | $-51.90MM | $-39.57MM |
| Stockholders Equity | $11.37MM | $-11.31MM | $1.64MM |
| Assets | $27.15MM | $28.18MM | $25.86MM |
| Operating Cash Flow | $-32.69MM | $-37.07MM | $-36.95MM |
| Capital expenditure | $0.07MM | $0.09MM | $0.02MM |
| Investing Cash Flow | $-0.03MM | $-0.08MM | $-0.02MM |
| Financing Cash Flow | $38.61MM | $42.32MM | $36.70MM |
| Earnings Per Share** | $-6.96 | $-4.25 | $-2.58 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.